Bone mineral density and bone turnover in male master track and field athletes aged 40-64 by Nowak, Alicija et al.
Bone mineral density and bone turnover in male masters athletes aged
40–64
ALICJA NOWAK1, ANNA STRABURZYN´SKA-LUPA2,3, KRZYSZTOF KUSY4,
JACEK ZIELIN´SKI4, DIETER FELSENBERG5, JO¨RN RITTWEGER6,
JOANNA KAROLKIEWICZ1, EWA STRABURZYN´SKA-MIGAJ7, &
ŁUCJA PILACZYN´SKA-SZCZES´NIAK1,3
1Department of Hygiene, University School of Physical Education in Poznan´, Poland, 2Department of Physiotherapy,
University School of Physical Education in Poznan´, Poland, 3Higher Vocational State School in Kalisz, Poland, 4Department
of Athletics, University School of Physical Education in Poznan´, Poland, 5Center of Muscle and Bone Research, Charite´ –
University Medicine, Free and Humboldt University Berlin, Germany, 6Institute for Biomedical Research into Human
Movement and Health, Manchester Metropolitan University, Alsager, UK, and 71st Department of Cardiology, University of
Medical Sciences in Poznan´, Poland
(Received 28 July 2009; revised 30 December 2009; accepted 12 January 2010)
Abstract
We evaluated areal bone mineral density (aBMD), bone mineral content (BMC), and markers of bone turnover in male
competitive masters athletes representing different training profile in the past and at present, aged 40–64 (14 endurance
runners, and 12 speed-power athletes), and non-sport controls (n¼ 13). Dual-energy X-ray absorptiometry measurements of
total body and regional aBMD, BMC and soft tissue composition were acquired. Serum concentrations of osteocalcin (OC),
C-terminal crosslinking telopeptide of type I collagen (CTX), tumour necrosis factor-a (TNF-a), total testosterone (TT),
free testosterone (FT) and insulin like growth factor-1 (IGF-1) were measured. Adjusted total and regional aBMD and BMC
(covariates: body mass, body height and age) were significantly greater in all measured regions in speed-power athletes than
in endurance athletes and control subjects, but adjusted aBMD and BMC values were not significantly different between
endurance athletes and controls. No differences in bone formation (OC), bone resorption (CTX), and serum concentrations
of TNF-a, TT, FT and IGF-1 were noted. This suggests that weight-bearing exercise in young age and the training
continuation in later life may be an important contributor to the aBMD and BMC in the middle age and in the elderly. It
seems also that training-related bone differences in men are not caused by present alterations in bone turn-over or
somatotropic effects. However, conclusions must be drawn with caution due to a large variability of biochemical markers.
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Introduction
Physical activity is an important factor modifying bone
tissue mass. It is well known that regular exercise
enhances peak bone mass and preserves the age-
related decreases in bone mineral density (BMD) [1].
Some investigators have shown that athletes after
many years of training or after the end of their sport
career have higher areal bone mineral density
(aBMD) in the most overloaded sites, depending on
the trained kind of sport, in comparison with non-
practicing subjects [2]. Especially, weight-bearing
exercises have osteogenic influence on bones [3].
In contrast with that, an excessive physical
activity may have a negative effect on the skeleton,
especially on sites containing a larger proportion of
trabecular bone, which is sensitive to endocrine
status [4,5]. Cross-sectional studies have revealed
that athletes practicing endurance running have
usually lower values of BMD in the lumbar spine
and femoral neck in comparison with those
practicing weight training, and some results show
the same or lower values in comparison with non-
practicing subjects [6,7].
Vigorous exercise increases bone mass mainly in
sites exposed to loading forces, but the physical
activity also influences bone metabolism by modifica-
tion of endocrine system [8]. It has been demon-
strated that regular intensive training affects, among
other things, the chronic increase in testosterone,
dehydroepiandrosterone and insulin-like growth
factor-1 (IGF-1) concentrations [9,10].
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However, the effect of exercise may depend on
the stage of age [8]. Animal studies demonstrate
that bone modelling does become less active in
adult age than during growing and bones appear
less responsive to the mechanical loading [11].
After the age of 40, physiological changes in bone
may be intensified by hormonal factors [12]. There
is a decrease of growth hormone secretion as well
as diminished concentration of IGF-1 in serum
[13]. Much evidence demonstrates gradual reduc-
tion of activity of interstitial cells (Leydig cells)
during ageing. Among other things, a decreased
concentration of total and free testosterone (FT) as
well as an increase in concentration of sex
hormone binding globulin in serum have been
observed [14].
Bone density in adults is known to decline with
age. Lanyon and Skerry [15] hypothesise that bone
loss contributes to diminished loading-related sti-
mulation resulting from a decline in both the
absolute level of physical activity and its osteogenic
potential. Although there is a certain number of
studies on weight-bearing exercise effects on bone
density and bone metabolism in young male athletes
[16,17,18], so far much fewer studies have been
conducted on highly trained male middle-aged and
elderly athletes. The existing studies on male
masters athletes usually do not combine bone
measures with metabolic parameters [19,20]. More-
over, sparse studies that join elements of com-
petitive sport participation, bone density/mineral
content and metabolic parameters in males relate
only to endurance trained masters athletes [21,22].
As yet, research of this kind, including also speed-
power trained masters athletes, has not been
undertaken.
Therefore, the aim of the study was to assess bone
mass density and bone turnover in male masters
athletes still involved in competitive sport, represent-
ing different training profile in young age and
adulthood, and exposed to dissimilar competition
requirements. The track and field athletics encom-
passes a variety of events and thus is a good example
for this purpose. We compared BMD, bone mineral
content (BMC), and bone turnover between endur-
ance runners, speed-power athletes and non-sport
controls.
Methods
The study was performed in 26 white male masters
track and field athletes, participants of the Eur-
opean Veterans Athletics Championships Stadia,
and 13 non-athletic controls. The age of all
subjects ranged from 40 to 64 years. They declared
good health status. Subjects with inflammatory
disorders, recent infections, diabetes mellitus, renal
or hepatic insufficiency, anorexia nervosa, smoking
and using hormonal therapy were not included into
the study.
Athletes
Athletes were divided into two categories according
to the declared type of sport event during the
competition: endurance athletes (long-distance
runners 5000 m, n¼ 14) and speed-power athletes
(seven sprinters 400 m, one high jumper, one long
jumper, two pentathlonists, one hammer thrower,
total n¼ 12). Four endurance athletes and four
speed-power athletes were current medalists of
European championships. All of them were regular
participants in international athletic championships.
One endurance athlete and three speed-power
athletes were not participating in competitive sport
in the young age. All other athletes were participating
in the same sport (athletics) and in the same kind of
event, i.e. current endurance runners were endur-
ance runners before the age of 30, and speed-power
athletes specialised in the same event or events of the
same character in the past and at present (shifts
within speed-power events were possible, e.g. be-
tween sprint and jumping). Detailed division by age
in categories 40–45, 46–50, 51–55, 56–60 and 61–64
was: 3, 7, 2, 2 and 0 subjects in endurance runners;
5, 2, 1, 1, and 3 subjects in speed-power athletes; 2,
7, 1, 2 and 1 subjects in controls, respectively.
Thirteen endurance runners and nine speed-power
athletes participated in competitive sport before the
age of 30. Athletes reported current training fre-
quency at least four times a week.
Controls recruitment
Control subjects were professionally active people,
volunteers recruited during the European Veterans
Athletic Championships Stadia. In total, 130 of
volunteers were examined. Inclusion criteria were
(1) age, body mass, body height and body mass index
(BMI) as similar as possible to athletes’ character-
istics, (2) good health status, (3) low level of physical
activity (52 h/week) and (4) lack of competitive
sport history in the past and at present. Selected 13
control subjects were healthy men, participating in
leisure time physical activity only 0.8+ 0.8 h per
week (including resistance or weight-bearing exer-
cise) in the year preceding recruitment and they have
never trained at the competitive level.
Health, training history and physical activity
The data regarding health and training or physical
activity history were obtained by means of a short
structured interview, administered by one of the
researchers to each participant. The interview en-
compassed basic information: past and present
diseases as well as medication (to exclude subjects
with serious disorders and illnesses), years of
competitive sport and specialisation before the age
of 30, starting age of masters training, masters sport
history, specialisation and sports level in masters
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category (places in national, European or world
championships), weekly training (athletes) and phy-
sical activity (controls) duration.
Weight and height measurement
Weight and height were measured using certified
digital medical scale WPT 60/150.O (Radwag,
Radom, Poland), accuracy 0.01 kg, with mechanical
measuring rod for height, accuracy 0.5 cm.
Bone densitometry
Dual-energy X-ray absorptiometry (DXA) measure-
ments of total-body and regional (arms, trunk,
thoracic spine, pelvis and legs) aBMD, total-body,
arms and legs BMC, soft tissue composition includ-
ing total fat and lean body mass (total, legs and arms)
were acquired on a Lunar Prodigy Advance densit-
ometer (GE Lunar Corp., Madison, WI, USA),
software enCORE 2006, using the standard whole
body protocol. Reproducibility of DXA data was not
assessed in this study, but is normally in the order of
1% (% CV) in our laboratory. The reproducibility of
the regional analysis of the Lunar Prodigy device was
reported by Wacker et al. [23]. They scanned 39
subjects (mean age 56.7 years, SD 13.7; mean BMI
25.3) in triplicate for total body. Precision values (%
CV) were 0.76% for total body BMD, and 1.68% for
total body BMC. Total body composition precision
values were 1.74% for per cent fat, 1.64% for fat
mass (g), and 1.15% for lean mass (g). Other studies,
conducted on younger adults, reported precision
0.64 at the total body BMD, 0.64–0.90 for total body
BMC, 0.41–0.88 for fat mass (g), 1.57–4.49 for lean
mass (g), and 0.7–1.7 at the spine [24–28].
Data obtained from DXA were averaged from the
right and left limbs. All scans were taken by the same
technician on the same machine. The Lunar device
was calibrated daily. Quality control of the DXA
scanner was undertaken following the manufacturer’s
instructions, and analysis of the scans was done with
the integrated software following the manufactuer’s
recommendations.
Biochemical analysis
Blood was collected between 8 and 10 a.m. after
12 h of fasting and 24 h without strenuous exercise.
Samples were centrifugated at 5000 rpm and 48C.
Serum was separated and stored at 7708C. Serum
concentrations of bone turnover markers: osteocalcin
(OC) as bone formation marker and C-terminal
telopeptide of type I collagen (CTX) as bone
resorption marker were determined by an immu-
noenzymatic ELISA method using tests of Quidel
Corporation (USA) and Nordic Bioscience (Den-
mark), respectively. Coefficients of variation were
6.6% (within-assay) and 8.5% (between-assay) for
OC, and 5.5% and 8.1% for CTX, respectively.
Tumour necrosis factor-a (TNF-a), a member of a
group of cytokines, was used as a marker of systemic
inflammation. The concentration of TNF-a was
measured by an immunoenzymatic high-sensitivity
ELISA method and high sensitivity test of Bender
MedSystems Inc. (Austria). Precision values were
8.5% for within-assay variation and 8.5% for
between-assay variation. Level of total testosterone
(TT) in serum was determined using radioimmu-
noassay by Orion Diagnostica (Finland), % CV 4.3%
for intra-assay and 8.1% for inter-assay variation.
Concentrations of FT, IGF-1 in serum were analysed
by radioimmunological method using BioSource
(Belgium) kit, within-assay precision 5.7% and
between-assay precision 6.2% for FT, and 2.9%
and 5.1% for IGF-1, respectively. Biochemical
analyses were performed in the analytical laboratory
certificated ISO:9001:2008.
The study protocol was approved by the Ethics
Committee for Human Research at The Poznan´
University of Medical Sciences, and all participants
gave their informed consent.
Statistical analysis
The Shapiro–Wilk test was used to check the data for
normal distribution and the Levene’s test for homo-
geneity of variance in each group of athletes and
control subjects. As most variables were normally
distributed and homogenous, parametric methods
were applied for the whole analysis. Comparisons
between three groups of subjects (endurance, speed-
power and controls) for age, physical activity,
somatic parameters, bone densitometry, and bio-
chemical indices were made using one-way analysis
of variance (ANOVA) and Scheffe´-test as a post hoc
analysis. Comparisons between both groups of
athletes with respect to the training characteristics
were done with T-test. A general linear model was
used for each measure of aBMD and BMC as the
response variable, and subject group (endurance
athletes/speed-power athletes/controls) as main fac-
tors. Age, weight and height were included as
covariates. Using analysis of covariance (ANCOVA),
we obtained adjusted means and differences. The
Pearson correlation coefficient was calculated in
order to find associations between measured vari-
ables. All calculations were carried out with Statistica
8.0 software (StatSoft Inc., Tulsa, OK, USA).
Results
Descriptive characteristics of the examined groups of
subjects are given in Table I. Athletes and controls
did not differ significantly as regards age, height and
BMI, although endurance runners were shorter by
about 3 cm and had lower BMI value by about 2 kg/
cm2 than speed-power athletes and controls. Endur-
ance runners had significantly lower body
mass (p5 0.05) than other subjects. Significant
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differences were also observed in per cent fat mass
(p5 0.001). Definitely higher fat content was re-
vealed in controls (22.3%): almost twice more than
in each group of athletes (about 12%). The highest
level of lean body mass was shown in speed-power
athletes (65151 g), who differed significantly from
both endurance runners and controls by about
7000 g (p5 0.05). The mean duration of sport
participation in young age was very similar in both
groups of athletes (about 11 years). The mean
starting age of masters training (at the age of 35),
the mean duration of masters sport participation
(almost 15 years), and mean total competitive
training experience (26 years) also did not differ
significantly between the two groups of athletes. The
only training characteristic that was significantly
different between athletes was weekly training vo-
lume, which was higher in endurance runners than in
speed-power athletes (p5 0.05).
Table II contains crude mean values of whole body
and regional aBMD and total BMC. The one-way
ANOVA showed significant differences between
three groups in all mean values of total and regional
aBMD. The post hoc Scheffe´-test revealed signifi-
cantly higher values in speed-power athletes than in
endurance athletes and controls for total-body
aBMD (by 8.9% and 10.7%, respectively), arms
(by 11.5% and 10.5%, respectively), trunk (by 11.8%
and 9.5%, respectively), thoracic spine (by 13.9%
and 10.6%, respectively), pelvis (by 12.1% in both
cases) and legs aBMD (by 10.5% and 14.5%,
respectively). Mean aBMD values in endurance
athletes and control subjects were very similar and
did not differ significantly. Similar significant differ-
ences were observed in crude mean values of total
body and legs BMC. Total body BMC was higher in
speed-power athletes than in endurance runners and
controls by 14.7% and 14.1%, and legs BMC by
Table I. Mean values+SD of age, somatic parameters and training characteristics in endurance athletes, speed-power athletes and controls.
ANOVA refers to comparisons between all three groups of athletes and controls, T-test refers to comparisons between two groups of athletes.
p-level
Endurance (n¼14) Speed-power (n¼ 12) Controls (n¼ 13) ANOVA/T-test*
Age (years) 49.2+5.4 50.6+9.2 49.4+ 5.7 n.s.
Weight (kg) 69.8+6.2{,x 78.8+13.9{ 77.6+ 9.0{ 50.05
Height (cm) 176.0+4.5 179.6+9.0 179.0+ 4.2 n.s.
Body mass index (kg/m2) 22.5+1.3 24.3+3.2 24.2+ 1.9 n.s.
Fat mass (%) 11.5+4.3{ 12.6+7.3{ 22.3+4.6{,x 50.001
Lean body mass (g) 58912+4412x 65151+8534{,{ 57707+ 5206x 50.05
Training experience before the age of 30 (years) 11.0+4.5 11.5+8.0 – n.s.
Starting age of masters training (years) 34.6+7.4 35.8+6.9 – n.s.
Masters training experience (years) 14.6+7.6 14.8+9.5 – n.s.
Total training experience (years) 26.6+10.6 26.3+9.5 – n.s.
Training volume (h/week) 7.3+1.5x 6.2+1.2{ – 50.05
n.s., not significant.
*ANOVA for age and somatic characteristics (three groups of subjects), T-test for training characteristics (two groups of athletes).
{Significantly different from controls.
{Significantly different from endurance athletes.
xSignificantly different from speed-power athletes.
Table II. Crude mean values+SD of whole body and regional aBMD and BMC in endurance athletes, speed-power athletes and controls.
Endurance
(n¼ 14)
Speed-power
(n¼ 12)
Controls
(n¼13)
One-way ANOVA
p-level Effect size Statistical power (a¼0.05)
aBMD total-body (g/cm2) 1.23+ 0.08{ 1.34+ 0.10*,{ 1.21+ 0.09{ 50.01 0.31 0.94
aBMD arms (g/cm2) 1.04+ 0.12{ 1.16+ 0.14*,{ 1.05+ 0.12{ 50.05 0.18 0.66
aBMD trunk (g/cm2) 0.93+ 0.06{ 1.04+ 0.09*,{ 0.95+ 0.06{ 50.001 0.34 0.97
aBMD thor. spine (g/cm2) 1.01+ 0.08{ 1.15+ 0.14*,{ 1.04+ 0.08 50.01 0.27 0.89
aBMD pelvis (g/cm2) 1.16+ 0.09{ 1.30+ 0.12*,{ 1.16+ 0.10{ 50.05 0.30 0.93
aBMD legs (g/cm2) 1.43+ 0.12{ 1.58+ 0.13*,{ 1.38+ 0.11{ 50.001 0.35 0.97
Total-body BMC (g) 3070+ 309{ 3521+ 551*,{ 3086+ 307{ 50.01 0.22 0.79
Arms BMC (g) 454+ 47 504+ 76 455+ 52 n.s. 0.14 0.53
Trunk BMC (g) 891+ 135{ 1084+ 231{ 948+ 126 50.05 0.20 0.72
Legs BMC (g) 1286+ 118{ 1453+ 219*,{ 1231+ 126{ 50.01 0.28 0.90
n.s., not significant.
*Significantly different from controls.
{Significantly different from endurance athletes.
{Significantly different from speed-power athletes.
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13.0% and 18.0%, respectively. Mean value of trunk
BMC was also the highest in speed-power athletes
(by 21.7% and 14.3%, respectively) but a significant
difference was noted only between endurance and
speed-power athletes. In spite of the tendency toward
higher arms BMC in speed-power athletes compared
to other groups (by 11.0% and 10.8%, respectively),
significant differences were not shown.
After adjusting aBMD and BMC values for age,
weight and height, the obtained picture of adjusted
means and differences turned out to be more
uniform (Table III). All bone parameters differed
significantly between examined groups. The highest
values were observed always in speed-power athletes,
exceeding considerably those of endurance runners
and controls who did not differ between each other.
Differences expressed as percentage of speed-power
athletes’ values were larger for controls (from 9.6%
for trunk BMD to 17.8% for legs BMC) than for
endurance athletes (from 6.7% for total body BMC
to 9.4% for arms aBMD).
Table IV contains mean values of biochemical
indices in both athletic groups and controls. Con-
centrations of OC, CTX, TT, FT, TNF-a and IGF-
1 did not significantly differ between all investigated
groups. However, the variability of these parameters
was very high, and the statistical power of ANOVA
very low.
The significant positive correlation between legs
aBMD and total training experience (r¼ 0.57,
p5 0.05) in endurance runners was found. There
were revealed no relationships between total/regional
aBMD and biochemical indices in all investigated
groups.
Discussion
In this study, total and regional aBMDs and contents
were compared as well as levels of biochemical
markers of bone turnover and hormonal indices were
assessed to evaluate the bone metabolism in 40–64
year old masters athletes.
Bone parameters
The comparison showed that aBMD values of the
whole skeleton, of the examined regions (spine,
trunk, pelvis, arms, legs) as well as BMC values
(total-body, arms, trunk, legs) were significantly
higher in speed-power athletes compared with
endurance athletes and controls, for both crude
and adjusted values, mostly on a very high level of
Table III. Age-, weight- and height-adjusted mean values+SE of whole body and regional aBMD, and BMC in endurance athletes, speed-
power athletes and controls.
Endurance (n¼14) Speed-power (n¼12) Controls (n¼ 13)
ANCOVA
p-level Effect size
Statistical power
(a¼ 0.05)
aBMD total-body (g/cm2) 1.24+ 0.02{ 1.33+ 0.02*,{ 1.20+ 0.02{ 50.01 0.33 0.94
aBMD arms (g/cm2) 1.06+ 0.03{ 1.16+ 0.03*,{ 1.04+ 0.03{ 50.05 0.17 0.58
aBMD trunk (g/cm2) 0.95+ 0.02{ 1.03+ 0.02*,{ 0.94+ 0.02{ 50.01 0.33 0.95
aBMD thor. spine (g/cm2) 1.05+ 0.02{ 1.13+ 0.03*,{ 1.03+ 0.02 50.05 0.23 0.77
aBMD pelvis (g/cm2) 1.19+ 0.03{ 1.29+ 0.03*,{ 1.15+ 0.03{ 50.01 0.29 0.88
aBMD legs (g/cm2) 1.44+ 0.03{ 1.57+ 0.03*,{ 1.37+ 0.03{ 50.001 0.37 0.97
Total-body BMC (g) 3220+ 74{ 3435+ 77*,{ 3021+ 73{ 50.01 0.32 0.93
Arms BMC (g) 472+ 13{ 494+ 13*,{ 447+ 12{ 50.05 0.17 0.60
Trunk BMC (g) 964+ 30{ 1040+ 32*,{ 918+ 30{ 50.05 0.20 0.68
Legs BMC (g) 1322+ 31{ 1422+ 32*,{ 1207+ 31{ 50.001 0.42 0.99
n.s., not significant.
*Significantly different from controls.
{Significantly different from endurance athletes.
{Significantly different from speed-power athletes.
Table IV. Biochemical parameters (mean+SD) in endurance athletes, speed-power athletes and controls.
Endurance (n¼14) Speed-power (n¼12) Controls (n¼13)
One-way ANOVA
p-level Effect size Statistical power (a¼ 0.05)
OC (ng/ml) 10.90+ 3.56 11.78+ 2.94 12.00+4.00 n.s. 0.02 0.10
CTX (ng/ml) 0.66+ 0.29 0.74+ 0.25 0.74+0.33 n.s. 0.02 0.10
TT (nmol/l) 18.34+ 3.59 20.08+ 6.75 18.08+6.06 n.s. 0.03 0.12
FT (pg/ml) 8.81+ 2.64 8.80+ 3.24 7.46+5.93 n.s. 0.02 0.12
TNF-a (pg/ml) 0.96+ 1.99 0.34+ 0.39 0.23+0.15 n.s. 0.07 0.28
IGF-1 (ng/ml) 153.02+ 72.87 144.69+ 56.05 143.44+51.62 n.s. 0.01 0.06
n.s., not significant.
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statistical significance (Table II and III). The
limitation of our study is that the regional analysis
of aBMD cannot be supported by separate scans
for loaded sites, e.g. proximal femur and lumbar
spine. In an overview of cross-sectional studies,
Suominen [7] has demonstrated higher BMD and
BMC in middle-aged males from various sports in
several fragments of the skeleton in comparison
with non-athletes. The greatest differences in bone
mineral mass have been observed in sites rich in
trabecular bone, but the differences were lower in
elderly.
Our middle-aged endurance runners did not
differ significantly from the control group as
regards adjusted aBMD and BMC. In younger
endurance runners, a lower mineral density in
lumbar spine and/or proximal femur [4,29] and in
distal parts of lower limbs [30] has been demon-
strated in comparison with athletes running shorter
distances or even with non-exercisers. In other
studies on older athletes, differences concern the
most loaded sites during running (lower limbs) as a
rule. In several studies, no significant differences or
lower level in lumbar vertebrae, lumbar spine and
forearm aBMD in middle-aged to older distance-
running males have been found compared to
individuals who run less or not at all, whereas
significant differences in more loaded sites (legs,
femoral neck, proximal femur, trochanterion,
Ward’s triangle, calcaneus) have been revealed
[4,19,21,22,31,32]. Similar locations (lower limbs,
calcaneus, femoral neck, pelvis) were connected
with the differences between young competitive
male runners and controls [33,34].
Beside the location of the mechanical load, the
running volume also seems to be an important factor,
affecting bone density and mass. Very high volume
masters runners usually do not differ from controls
or have lower BMD or BMC than non-sport
controls, and the negative association remains
significant even when the model is corrected for
body size. The volume threshold is about 90–95 km a
week: above this training load no further increases
are observed in BMD and BMC [5,22,30]. In our
research, running volume in kilometers was not
collected and the lack of differences between runners
and controls cannot be interpreted in these terms.
We presume that the above-mentioned volume
threshold was not exceeded by our subjects, because
they run on average 7.3 h a week, i.e. less than high
(9.1 h/week, 69 km/week) and very high volume
runners (10.6 h/week, 101 h/week) in the study of
MacKelvie et al. [22]. This presumption is reinforced
by the tendency toward higher values of adjusted
aBMD and BMC in endurance athletes than in
controls in our study. This suggests a small but
positive training response as a result of a running
volume below the ‘risky’ threshold.
The higher values of bone mass in speed-power
athletes compared to distance runners may result
from the differences in training type in young age
continued in masters sport, specific to a given type of
physical exertion. Speed-power athletic events are
characterised by short duration, extremely high
intensity (maximum and supermaximum), and large,
impulsive loads on bone. The largest mechanical
loads come from jumping down from a height or
from working muscle contractions [35]. Although we
did not collect detailed information on the structure
of training loads of athletes, we suppose that speed-
power athletes used much more heavy and vigorous
exercises (e.g. jumping, weight exercises) in their
training than endurance runners did. Conzelmann
[36] has revealed considerable differences in the
structure of trainings loads between best German
distance runners and sprinters aged 45–70. First and
foremost, over 60% of sprinters developed regularly
their strength and power, and almost a half of them
used additional external resistance. The athletes
devoted on average 0.61–1.48 training lessons per
week to strength exercises, depending on training
phase and specialisation. Moreover, 33–55% of
sprinters practiced jumping exercises (0.31–1.06
training lessons per week). In contrast to the
sprinters, only 10% of long-distance runners used
any training form other than running (strength,
flexibility, coordination, general fitness). In endur-
ance runners who participated in resistance training
at least twice-a-week, Hind et al. [37] have demon-
strated greater lumbar spine aBMD than in athletes
using only endurance training. Sprint running and
depth or drop jumps (jumping down from a height)
influence significantly skeleton load and, conse-
quently, bone osteogenic reaction. Studies in men
have shown that the workload is of greater impor-
tance for increase in bone mass than number of
repetitions [38]. However, Karlsson [39] has re-
ported that loading on mature bone is no more
effective than normal daily use.
We found the correlation between legs aBMD and
lifetime training experience in endurance runners but
not in speed-power athletes. The results of similar
studies are divergent. Daly and Bass [40] have
detected no relationships between the lifetime total
time spent participating in sport and leisure activities
with any bone parameter. However, the time of
participation in weight-bearing activities was an
important determinant of bone size, quality and
strength, but not areal or volumetric BMD at loaded
sites in older men. They concluded that participation
in weight-bearing exercise in early to mid-adulthood
appears to be an important component of improved
bone size and strength in old age. Suominen and
Rahkila [31] have observed no relationship between
training years and volumetric BMD as well as BMC
of calcaneus in much older athletes aged 70–81
(endurance, strength and speed). Wiswell et al. [20]
have found that hip and spine aBMD are maintained
over a 4- to 5-year period in master runners ranging
in age from 40 to 80 years old. They concluded that
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bone density can be maintained by running in older
active men.
Biochemical parameters
Using biochemical markers of bone turnover, hor-
monal indices and TNF-a, we tried to understand
the mechanism responsible for exercise-related ef-
fects on bone mass. Differences in bone turnover
were not observed in our study. OC levels (marker of
bone formation) as well as CTX levels (resorption
marker) were not significantly different between
groups (Table III). We also found no differences in
hormonal indices levels (TT, FT) between endur-
ance and speed-power athletes and no relationships
between training volume and bone metabolic status
in the both groups of athletes. The main limitation of
our results is a high variability of these parameters
resulting in a very low statistical power of ANOVA
(effect size ranged from 0.01 to 0.07, statistical power
from 0.06 to 0.028) and thus the results must be
interpreted with caution.
Except for the above-mentioned obvious short-
coming, there are two other possible explanations of
the lack of differences. First, training experience of
studied athletes before the age of 30 (on average 11
years) indicates that they started training at their
young age. Therefore, the influence of training on
hormonal status and bone tissue metabolism in the
earlier lifetime can not be excluded. Hetland et al. [5]
have demonstrated increased (by 20–30%) levels of
bone turnover markers in high volume running
athletes (4100 km/week) compared to controls.
Concentrations of bone turnover markers were
positively related to the weekly running distance.
However, endurance athletes in our study differ from
Hetland’s participants in age (athletes in our study
are older by 16 years on average). In contrast, Brahm
et al. [21] have revealed lower levels of bone
formation and bone resorption markers in serum in
runners than in controls by 18.0% and 22.2%,
respectively. But it is to stress that the age range of
subjects was very wide (19–54 years old).
Exercise in the older age plays a lesser role in
increasing bone mass in comparison with childhood
or maturation [41]. Frost [8] has reported that
physical activity does not significantly increase bone
mass in ageing adults, partly due to age-related
decrease in cellular responsiveness to hormones,
and fewer stem cells to create the osteoblasts needed
to add bone. Bennell et al. [29] have demonstrated,
like in our study, similar levels of bone metabolic
markers in endurance and power athletes, despite
differences in bone mass indicating the importance of
childhood physical activity. This supports the hypoth-
esis that differences in bone mass arise during the
young years.
Secondly, the phase of the 1-year training cycle,
when biochemical assessment in our athletes was
done, could also play a role in the metabolic status. It
can be supposed that athletes in our study were
already adapted to the specific training loads and
competition demands at the moment of the exam-
ination, which was the competition period. Thus, the
bone metabolism was no longer intensified. Changes
of bone biochemical markers could occur in earlier
phases of the training cycle, in the preparation
period, when the trainings loads (especially training
volume) are increasing. The variation in markers of
bone formation along with the training periods of the
1-year cycle has been observed in young adult
endurance runners [42]. Further investigation is
needed to find if similar variation occurs also in
masters athletes.
In the present study, no significant differences
were found in levels of investigated metabolic
parameters like TNF-a, IGF-1 and testosterone
between studied groups. The interpretation is diffi-
cult due to a high variability of these parameters.
TNF-a is a member of a group of cytokines and a
marker of systemic inflammation. Pathologic bone
resorption is mediated largely by increased produc-
tion of cytokines [43]. There is an increased
production of TNF-a during ageing. TNF-a med-
iates both survival and cell death signals. There are
suggestions that the measurement of TNF-a may
give a picture of the mechanism regulating bone
ageing [44]. Elosua et al. [45] have demonstrated
that men aged 65 or more practicing moderate and
high intensity physical activity had significantly lower
concentrations of TNF-a than sedentary men.
Regular training may also alter the secretion of
IGF-1 [10]. Poehlman and Copeland [46] have
shown that lower levels of IGF-1 with ageing in men
are related to diminished physical activity. Arii et al.
[47] have revealed significantly higher IGF-1 levels in
masters athletes aged 68+ 6 than in sedentary
controls. Also, a lack of connection between IGF-1
concentration and physical performance has been
reported [48,49]. Cooper et al. [48] have found
comparable plasma IGF-1 level in elderly long-term
endurance-trained master runners and sedentary
elderly men.
MacKelvie et al. [22] have revealed no differences
in TT and FT between high volume runners and
controls; however the within group variances were
very high, like in our study. Although testosterone
levels were negatively associated with weekly training
volume, the reported values fell within the normal
healthy range and no relation to BMD has been
found. Suominen and Rahkila [31] have also
demonstrated no correlation between BMD and
serum TT. However, a significant increase in
testosterone levels has been observed in both young
and older men following a 10-week strength-power
training program [9], indicating that also older men
can make physiological adaptations in the endocrine
system with resistance training, but the plasticity of
the system was limited compared to younger
subjects. Tissandier et al. [10] have observed only
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the tendency (p¼ 0.08) to higher levels of FT in old
trained male subjects.
In summary, this study showed, in line with
previous reports [4,22,29], that power-speed athletes
have greater aBMD than endurance athletes. This
suggests that weight-bearing exercise with large
loading forces in young age and the training
continuation in later life appears to be an important
contributor to the aBMD in the middle age and in
the elderly. In addition to this, there was not any
difference in bone resorption, bone formation
markers, serum levels of IGF-1, TNF-a and testos-
terone. This would suggest that differences in bone
between power-speed athletes, distance runners and
controls are not caused by present alterations in bone
turn-over or somatotropic effects. However, a very
high variability of biochemical parameters, which
resulted in low power of statistical analysis, con-
siderably limits this conclusion. Much larger samples
are needed to detect the relationship between bone
and metabolic parameters. Our earlier study on
young endurance runners has revealed the change-
ability of bone metabolic indices during the 1-year
training cycle [42]. Therefore, an investigation of
bone turnover markers during longer training periods
in middle-aged and elderly male athletes is recom-
mended for future research. Moreover, the BMD
measurement of more sensitive sites like femoral
neck or lumbar spine should be included in the
analysis to assess the bone parameters in athletes.
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